nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—NR0B1—Vincristine—lymphatic system cancer	0.652	1	CbGbCtD
Vorinostat—HDAC11—Signaling events mediated by HDAC Class II—BCL6—lymphatic system cancer	0.0219	0.149	CbGpPWpGaD
Vorinostat—HDAC6—Signaling events mediated by HDAC Class II—BCL6—lymphatic system cancer	0.0183	0.125	CbGpPWpGaD
Vorinostat—HDAC4—Signaling events mediated by HDAC Class II—BCL6—lymphatic system cancer	0.0166	0.113	CbGpPWpGaD
Vorinostat—Gastrointestinal toxicity—Teniposide—lymphatic system cancer	0.0147	0.0758	CcSEcCtD
Vorinostat—HDAC9—Signaling events mediated by HDAC Class II—BCL6—lymphatic system cancer	0.0143	0.0975	CbGpPWpGaD
Vorinostat—HDAC3—Signaling events mediated by HDAC Class II—BCL6—lymphatic system cancer	0.0129	0.0876	CbGpPWpGaD
Vorinostat—NCOR1—Mecp2 and Associated Rett Syndrome—BCL6—lymphatic system cancer	0.0098	0.0668	CbGpPWpGaD
Vorinostat—Gastrointestinal toxicity—Carmustine—lymphatic system cancer	0.00829	0.0426	CcSEcCtD
Vorinostat—Ureteric obstruction—Mitoxantrone—lymphatic system cancer	0.00771	0.0396	CcSEcCtD
Vorinostat—HDAC1—Negative epigenetic regulation of rRNA expression—RRP8—lymphatic system cancer	0.00705	0.048	CbGpPWpGaD
Vorinostat—HDAC1—Epigenetic regulation of gene expression—RRP8—lymphatic system cancer	0.00625	0.0426	CbGpPWpGaD
Vorinostat—HDAC3—Circadian rythm related genes—PROX1—lymphatic system cancer	0.0056	0.0381	CbGpPWpGaD
Vorinostat—Myelosuppression—Teniposide—lymphatic system cancer	0.00516	0.0265	CcSEcCtD
Vorinostat—NCOR1—Circadian rythm related genes—PROX1—lymphatic system cancer	0.00514	0.0351	CbGpPWpGaD
Vorinostat—HDAC2—Negative epigenetic regulation of rRNA expression—RRP8—lymphatic system cancer	0.00454	0.031	CbGpPWpGaD
Vorinostat—Myelosuppression—Fludarabine—lymphatic system cancer	0.00454	0.0233	CcSEcCtD
Vorinostat—HDAC1—Circadian rythm related genes—PROX1—lymphatic system cancer	0.00419	0.0286	CbGpPWpGaD
Vorinostat—HDAC2—Epigenetic regulation of gene expression—RRP8—lymphatic system cancer	0.00403	0.0275	CbGpPWpGaD
Vorinostat—Ureteric obstruction—Methotrexate—lymphatic system cancer	0.00384	0.0197	CcSEcCtD
Vorinostat—Gastrointestinal toxicity—Methotrexate—lymphatic system cancer	0.00384	0.0197	CcSEcCtD
Vorinostat—HDAC6—Clofarabine—Fludarabine—lymphatic system cancer	0.00356	0.514	CbGdCrCtD
Vorinostat—Deep vein thrombosis—Fludarabine—lymphatic system cancer	0.0035	0.018	CcSEcCtD
Vorinostat—HDAC6—Clofarabine—Cytarabine—lymphatic system cancer	0.00336	0.486	CbGdCrCtD
Vorinostat—Myelosuppression—Bleomycin—lymphatic system cancer	0.00333	0.0171	CcSEcCtD
Vorinostat—Myelosuppression—Carmustine—lymphatic system cancer	0.0029	0.0149	CcSEcCtD
Vorinostat—Myelosuppression—Vincristine—lymphatic system cancer	0.00277	0.0142	CcSEcCtD
Vorinostat—HDAC2—Circadian rythm related genes—PROX1—lymphatic system cancer	0.0027	0.0184	CbGpPWpGaD
Vorinostat—Myelosuppression—Mitoxantrone—lymphatic system cancer	0.0027	0.0139	CcSEcCtD
Vorinostat—Proteinuria—Fludarabine—lymphatic system cancer	0.00242	0.0124	CcSEcCtD
Vorinostat—Protein urine present—Fludarabine—lymphatic system cancer	0.00239	0.0123	CcSEcCtD
Vorinostat—HDAC2—Direct p53 effectors—BCL6—lymphatic system cancer	0.00219	0.0149	CbGpPWpGaD
Vorinostat—Sepsis—Teniposide—lymphatic system cancer	0.0021	0.0108	CcSEcCtD
Vorinostat—Serum creatinine increased—Mitoxantrone—lymphatic system cancer	0.00206	0.0106	CcSEcCtD
Vorinostat—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00196	0.0101	CcSEcCtD
Vorinostat—Abscess—Carmustine—lymphatic system cancer	0.00172	0.00884	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.00154	0.00793	CcSEcCtD
Vorinostat—NR0B1—Gene Expression—RRP8—lymphatic system cancer	0.00151	0.0103	CbGpPWpGaD
Vorinostat—Alopecia—Mechlorethamine—lymphatic system cancer	0.00146	0.00749	CcSEcCtD
Vorinostat—Pancytopenia—Teniposide—lymphatic system cancer	0.00144	0.00741	CcSEcCtD
Vorinostat—Proteinuria—Mitoxantrone—lymphatic system cancer	0.00144	0.0074	CcSEcCtD
Vorinostat—Dehydration—Fludarabine—lymphatic system cancer	0.00144	0.00738	CcSEcCtD
Vorinostat—Protein urine present—Mitoxantrone—lymphatic system cancer	0.00142	0.0073	CcSEcCtD
Vorinostat—Neutropenia—Teniposide—lymphatic system cancer	0.00142	0.0073	CcSEcCtD
Vorinostat—Pulmonary embolism—Carmustine—lymphatic system cancer	0.00136	0.007	CcSEcCtD
Vorinostat—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00128	0.0066	CcSEcCtD
Vorinostat—NCOR1—Gene Expression—RRP8—lymphatic system cancer	0.00128	0.00873	CbGpPWpGaD
Vorinostat—Pancytopenia—Fludarabine—lymphatic system cancer	0.00127	0.00651	CcSEcCtD
Vorinostat—Neutropenia—Fludarabine—lymphatic system cancer	0.00125	0.00641	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00124	0.00637	CcSEcCtD
Vorinostat—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.0012	0.00619	CcSEcCtD
Vorinostat—Sepsis—Carmustine—lymphatic system cancer	0.00118	0.00607	CcSEcCtD
Vorinostat—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00117	0.00603	CcSEcCtD
Vorinostat—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00117	0.00599	CcSEcCtD
Vorinostat—Infection—Mechlorethamine—lymphatic system cancer	0.00116	0.00598	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle—NPM1—lymphatic system cancer	0.00115	0.00785	CbGpPWpGaD
Vorinostat—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00115	0.00589	CcSEcCtD
Vorinostat—Anorexia—Mechlorethamine—lymphatic system cancer	0.00112	0.00574	CcSEcCtD
Vorinostat—Sepsis—Mitoxantrone—lymphatic system cancer	0.0011	0.00564	CcSEcCtD
Vorinostat—Chills—Teniposide—lymphatic system cancer	0.00109	0.0056	CcSEcCtD
Vorinostat—Alopecia—Teniposide—lymphatic system cancer	0.00107	0.00552	CcSEcCtD
Vorinostat—HDAC1—Gene Expression—RRP8—lymphatic system cancer	0.00104	0.00712	CbGpPWpGaD
Vorinostat—Deep vein thrombosis—Methotrexate—lymphatic system cancer	0.00104	0.00533	CcSEcCtD
Vorinostat—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00102	0.00523	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.000988	0.00508	CcSEcCtD
Vorinostat—Embolism—Methotrexate—lymphatic system cancer	0.000982	0.00505	CcSEcCtD
Vorinostat—Anaemia—Teniposide—lymphatic system cancer	0.000978	0.00503	CcSEcCtD
Vorinostat—Chills—Fludarabine—lymphatic system cancer	0.000958	0.00493	CcSEcCtD
Vorinostat—Leukopenia—Teniposide—lymphatic system cancer	0.000947	0.00487	CcSEcCtD
Vorinostat—Alopecia—Fludarabine—lymphatic system cancer	0.000944	0.00485	CcSEcCtD
Vorinostat—Pancytopenia—Bleomycin—lymphatic system cancer	0.000929	0.00478	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.000918	0.00472	CcSEcCtD
Vorinostat—Chest pain—Teniposide—lymphatic system cancer	0.000901	0.00463	CcSEcCtD
Vorinostat—Hypokalaemia—Carmustine—lymphatic system cancer	0.000899	0.00462	CcSEcCtD
Vorinostat—Weight decreased—Bleomycin—lymphatic system cancer	0.000885	0.00455	CcSEcCtD
Vorinostat—Dehydration—Vincristine—lymphatic system cancer	0.000877	0.00451	CcSEcCtD
Vorinostat—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00086	0.00442	CcSEcCtD
Vorinostat—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00086	0.00442	CcSEcCtD
Vorinostat—Anaemia—Fludarabine—lymphatic system cancer	0.000859	0.00442	CcSEcCtD
Vorinostat—Infection—Teniposide—lymphatic system cancer	0.000858	0.00441	CcSEcCtD
Vorinostat—Myocardial infarction—Bleomycin—lymphatic system cancer	0.000855	0.00439	CcSEcCtD
Vorinostat—Dehydration—Mitoxantrone—lymphatic system cancer	0.000854	0.00439	CcSEcCtD
Vorinostat—Thrombocytopenia—Teniposide—lymphatic system cancer	0.000845	0.00434	CcSEcCtD
Vorinostat—HDAC11—Disease—NPM1—lymphatic system cancer	0.000844	0.00575	CbGpPWpGaD
Vorinostat—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.000836	0.0043	CcSEcCtD
Vorinostat—Leukopenia—Fludarabine—lymphatic system cancer	0.000832	0.00428	CcSEcCtD
Vorinostat—Pruritus—Mechlorethamine—lymphatic system cancer	0.000828	0.00426	CcSEcCtD
Vorinostat—Anorexia—Teniposide—lymphatic system cancer	0.000823	0.00423	CcSEcCtD
Vorinostat—Cough—Fludarabine—lymphatic system cancer	0.000811	0.00417	CcSEcCtD
Vorinostat—Pancytopenia—Carmustine—lymphatic system cancer	0.000811	0.00417	CcSEcCtD
Vorinostat—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000801	0.00412	CcSEcCtD
Vorinostat—Neutropenia—Carmustine—lymphatic system cancer	0.000798	0.0041	CcSEcCtD
Vorinostat—Abscess—Methotrexate—lymphatic system cancer	0.000797	0.0041	CcSEcCtD
Vorinostat—Pancytopenia—Vincristine—lymphatic system cancer	0.000774	0.00398	CcSEcCtD
Vorinostat—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00077	0.00396	CcSEcCtD
Vorinostat—Neutropenia—Vincristine—lymphatic system cancer	0.000762	0.00392	CcSEcCtD
Vorinostat—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000754	0.00387	CcSEcCtD
Vorinostat—Infection—Fludarabine—lymphatic system cancer	0.000754	0.00387	CcSEcCtD
Vorinostat—Decreased appetite—Teniposide—lymphatic system cancer	0.00075	0.00386	CcSEcCtD
Vorinostat—Vomiting—Mechlorethamine—lymphatic system cancer	0.000745	0.00383	CcSEcCtD
Vorinostat—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000743	0.00382	CcSEcCtD
Vorinostat—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000742	0.00382	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.000738	0.00379	CcSEcCtD
Vorinostat—Weight decreased—Vincristine—lymphatic system cancer	0.000737	0.00379	CcSEcCtD
Vorinostat—HDAC1—Cell Cycle—NPM1—lymphatic system cancer	0.000724	0.00494	CbGpPWpGaD
Vorinostat—Anorexia—Fludarabine—lymphatic system cancer	0.000723	0.00372	CcSEcCtD
Vorinostat—Weight decreased—Mitoxantrone—lymphatic system cancer	0.000718	0.00369	CcSEcCtD
Vorinostat—Proteinuria—Methotrexate—lymphatic system cancer	0.000717	0.00369	CcSEcCtD
Vorinostat—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000716	0.00368	CcSEcCtD
Vorinostat—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.000716	0.00368	CcSEcCtD
Vorinostat—Myocardial infarction—Vincristine—lymphatic system cancer	0.000712	0.00366	CcSEcCtD
Vorinostat—Protein urine present—Methotrexate—lymphatic system cancer	0.000708	0.00364	CcSEcCtD
Vorinostat—HDAC6—Disease—NPM1—lymphatic system cancer	0.000707	0.00482	CbGpPWpGaD
Vorinostat—Chills—Bleomycin—lymphatic system cancer	0.000703	0.00361	CcSEcCtD
Vorinostat—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000698	0.00359	CcSEcCtD
Vorinostat—Nausea—Mechlorethamine—lymphatic system cancer	0.000696	0.00358	CcSEcCtD
Vorinostat—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000694	0.00357	CcSEcCtD
Vorinostat—Alopecia—Bleomycin—lymphatic system cancer	0.000692	0.00356	CcSEcCtD
Vorinostat—Body temperature increased—Teniposide—lymphatic system cancer	0.000682	0.00351	CcSEcCtD
Vorinostat—Oedema peripheral—Carmustine—lymphatic system cancer	0.000673	0.00346	CcSEcCtD
Vorinostat—HDAC2—Gene Expression—RRP8—lymphatic system cancer	0.000673	0.00459	CbGpPWpGaD
Vorinostat—Decreased appetite—Fludarabine—lymphatic system cancer	0.00066	0.00339	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000655	0.00337	CcSEcCtD
Vorinostat—Fatigue—Fludarabine—lymphatic system cancer	0.000654	0.00336	CcSEcCtD
Vorinostat—Constipation—Fludarabine—lymphatic system cancer	0.000649	0.00333	CcSEcCtD
Vorinostat—HDAC4—Disease—NPM1—lymphatic system cancer	0.00064	0.00436	CbGpPWpGaD
Vorinostat—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00063	0.00324	CcSEcCtD
Vorinostat—Anaemia—Bleomycin—lymphatic system cancer	0.00063	0.00324	CcSEcCtD
Vorinostat—Asthenia—Teniposide—lymphatic system cancer	0.000619	0.00318	CcSEcCtD
Vorinostat—Pruritus—Teniposide—lymphatic system cancer	0.000611	0.00314	CcSEcCtD
Vorinostat—Leukopenia—Bleomycin—lymphatic system cancer	0.00061	0.00314	CcSEcCtD
Vorinostat—Alopecia—Carmustine—lymphatic system cancer	0.000604	0.0031	CcSEcCtD
Vorinostat—Body temperature increased—Fludarabine—lymphatic system cancer	0.0006	0.00308	CcSEcCtD
Vorinostat—Cough—Bleomycin—lymphatic system cancer	0.000595	0.00306	CcSEcCtD
Vorinostat—Diarrhoea—Teniposide—lymphatic system cancer	0.000591	0.00304	CcSEcCtD
Vorinostat—HDAC8—Disease—NPM1—lymphatic system cancer	0.00059	0.00402	CbGpPWpGaD
Vorinostat—Chest pain—Bleomycin—lymphatic system cancer	0.00058	0.00298	CcSEcCtD
Vorinostat—Alopecia—Vincristine—lymphatic system cancer	0.000577	0.00296	CcSEcCtD
Vorinostat—Chills—Mitoxantrone—lymphatic system cancer	0.00057	0.00293	CcSEcCtD
Vorinostat—Alopecia—Mitoxantrone—lymphatic system cancer	0.000561	0.00289	CcSEcCtD
Vorinostat—Infection—Bleomycin—lymphatic system cancer	0.000553	0.00284	CcSEcCtD
Vorinostat—HDAC9—Disease—NPM1—lymphatic system cancer	0.000552	0.00376	CbGpPWpGaD
Vorinostat—Anaemia—Carmustine—lymphatic system cancer	0.00055	0.00283	CcSEcCtD
Vorinostat—Vomiting—Teniposide—lymphatic system cancer	0.000549	0.00282	CcSEcCtD
Vorinostat—Sepsis—Methotrexate—lymphatic system cancer	0.000547	0.00281	CcSEcCtD
Vorinostat—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000545	0.0028	CcSEcCtD
Vorinostat—Asthenia—Fludarabine—lymphatic system cancer	0.000544	0.0028	CcSEcCtD
Vorinostat—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000542	0.00278	CcSEcCtD
Vorinostat—Headache—Teniposide—lymphatic system cancer	0.000541	0.00278	CcSEcCtD
Vorinostat—Pruritus—Fludarabine—lymphatic system cancer	0.000537	0.00276	CcSEcCtD
Vorinostat—Leukopenia—Carmustine—lymphatic system cancer	0.000533	0.00274	CcSEcCtD
Vorinostat—Anorexia—Bleomycin—lymphatic system cancer	0.00053	0.00273	CcSEcCtD
Vorinostat—Anaemia—Vincristine—lymphatic system cancer	0.000525	0.0027	CcSEcCtD
Vorinostat—Diarrhoea—Fludarabine—lymphatic system cancer	0.000519	0.00267	CcSEcCtD
Vorinostat—Nausea—Teniposide—lymphatic system cancer	0.000513	0.00264	CcSEcCtD
Vorinostat—Anaemia—Mitoxantrone—lymphatic system cancer	0.000511	0.00263	CcSEcCtD
Vorinostat—Leukopenia—Vincristine—lymphatic system cancer	0.000508	0.00261	CcSEcCtD
Vorinostat—Chest pain—Carmustine—lymphatic system cancer	0.000507	0.0026	CcSEcCtD
Vorinostat—HDAC3—Disease—NPM1—lymphatic system cancer	0.000496	0.00338	CbGpPWpGaD
Vorinostat—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000495	0.00254	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000485	0.00249	CcSEcCtD
Vorinostat—Decreased appetite—Bleomycin—lymphatic system cancer	0.000484	0.00249	CcSEcCtD
Vorinostat—Cough—Mitoxantrone—lymphatic system cancer	0.000483	0.00248	CcSEcCtD
Vorinostat—Infection—Carmustine—lymphatic system cancer	0.000482	0.00248	CcSEcCtD
Vorinostat—Vomiting—Fludarabine—lymphatic system cancer	0.000482	0.00248	CcSEcCtD
Vorinostat—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000475	0.00244	CcSEcCtD
Vorinostat—Headache—Fludarabine—lymphatic system cancer	0.000475	0.00244	CcSEcCtD
Vorinostat—Chest pain—Mitoxantrone—lymphatic system cancer	0.000471	0.00242	CcSEcCtD
Vorinostat—Lethargy—Methotrexate—lymphatic system cancer	0.000467	0.0024	CcSEcCtD
Vorinostat—Anorexia—Carmustine—lymphatic system cancer	0.000463	0.00238	CcSEcCtD
Vorinostat—Infection—Vincristine—lymphatic system cancer	0.00046	0.00237	CcSEcCtD
Vorinostat—NCOR1—Disease—NPM1—lymphatic system cancer	0.000456	0.00311	CbGpPWpGaD
Vorinostat—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000454	0.00233	CcSEcCtD
Vorinostat—Nausea—Fludarabine—lymphatic system cancer	0.000451	0.00232	CcSEcCtD
Vorinostat—Infection—Mitoxantrone—lymphatic system cancer	0.000448	0.00231	CcSEcCtD
Vorinostat—Shock—Mitoxantrone—lymphatic system cancer	0.000444	0.00228	CcSEcCtD
Vorinostat—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000442	0.00227	CcSEcCtD
Vorinostat—Anorexia—Vincristine—lymphatic system cancer	0.000442	0.00227	CcSEcCtD
Vorinostat—Body temperature increased—Bleomycin—lymphatic system cancer	0.00044	0.00226	CcSEcCtD
Vorinostat—Anorexia—Mitoxantrone—lymphatic system cancer	0.00043	0.00221	CcSEcCtD
Vorinostat—Decreased appetite—Carmustine—lymphatic system cancer	0.000422	0.00217	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000419	0.00215	CcSEcCtD
Vorinostat—Constipation—Carmustine—lymphatic system cancer	0.000415	0.00213	CcSEcCtD
Vorinostat—Decreased appetite—Vincristine—lymphatic system cancer	0.000403	0.00207	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0004	0.00206	CcSEcCtD
Vorinostat—Fatigue—Vincristine—lymphatic system cancer	0.0004	0.00205	CcSEcCtD
Vorinostat—Asthenia—Bleomycin—lymphatic system cancer	0.000399	0.00205	CcSEcCtD
Vorinostat—Constipation—Vincristine—lymphatic system cancer	0.000396	0.00204	CcSEcCtD
Vorinostat—Pruritus—Bleomycin—lymphatic system cancer	0.000394	0.00202	CcSEcCtD
Vorinostat—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000392	0.00202	CcSEcCtD
Vorinostat—Fatigue—Mitoxantrone—lymphatic system cancer	0.000389	0.002	CcSEcCtD
Vorinostat—Constipation—Mitoxantrone—lymphatic system cancer	0.000386	0.00198	CcSEcCtD
Vorinostat—Body temperature increased—Carmustine—lymphatic system cancer	0.000384	0.00197	CcSEcCtD
Vorinostat—Pancytopenia—Methotrexate—lymphatic system cancer	0.000376	0.00193	CcSEcCtD
Vorinostat—HDAC1—Disease—NPM1—lymphatic system cancer	0.000372	0.00253	CbGpPWpGaD
Vorinostat—Neutropenia—Methotrexate—lymphatic system cancer	0.00037	0.0019	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000368	0.00189	CcSEcCtD
Vorinostat—Body temperature increased—Vincristine—lymphatic system cancer	0.000366	0.00188	CcSEcCtD
Vorinostat—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000357	0.00183	CcSEcCtD
Vorinostat—Vomiting—Bleomycin—lymphatic system cancer	0.000354	0.00182	CcSEcCtD
Vorinostat—Asthenia—Carmustine—lymphatic system cancer	0.000348	0.00179	CcSEcCtD
Vorinostat—Asthenia—Vincristine—lymphatic system cancer	0.000333	0.00171	CcSEcCtD
Vorinostat—Diarrhoea—Carmustine—lymphatic system cancer	0.000332	0.00171	CcSEcCtD
Vorinostat—Nausea—Bleomycin—lymphatic system cancer	0.00033	0.0017	CcSEcCtD
Vorinostat—Asthenia—Mitoxantrone—lymphatic system cancer	0.000324	0.00166	CcSEcCtD
Vorinostat—Dizziness—Carmustine—lymphatic system cancer	0.000321	0.00165	CcSEcCtD
Vorinostat—Diarrhoea—Vincristine—lymphatic system cancer	0.000317	0.00163	CcSEcCtD
Vorinostat—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000309	0.00159	CcSEcCtD
Vorinostat—Vomiting—Carmustine—lymphatic system cancer	0.000309	0.00159	CcSEcCtD
Vorinostat—Dizziness—Vincristine—lymphatic system cancer	0.000307	0.00158	CcSEcCtD
Vorinostat—Headache—Carmustine—lymphatic system cancer	0.000304	0.00156	CcSEcCtD
Vorinostat—Vomiting—Vincristine—lymphatic system cancer	0.000295	0.00151	CcSEcCtD
Vorinostat—Headache—Vincristine—lymphatic system cancer	0.00029	0.00149	CcSEcCtD
Vorinostat—Nausea—Carmustine—lymphatic system cancer	0.000288	0.00148	CcSEcCtD
Vorinostat—Vomiting—Mitoxantrone—lymphatic system cancer	0.000287	0.00148	CcSEcCtD
Vorinostat—Chills—Methotrexate—lymphatic system cancer	0.000284	0.00146	CcSEcCtD
Vorinostat—Headache—Mitoxantrone—lymphatic system cancer	0.000283	0.00145	CcSEcCtD
Vorinostat—Alopecia—Methotrexate—lymphatic system cancer	0.00028	0.00144	CcSEcCtD
Vorinostat—Nausea—Vincristine—lymphatic system cancer	0.000275	0.00142	CcSEcCtD
Vorinostat—Dysgeusia—Methotrexate—lymphatic system cancer	0.00027	0.00139	CcSEcCtD
Vorinostat—Nausea—Mitoxantrone—lymphatic system cancer	0.000268	0.00138	CcSEcCtD
Vorinostat—Anaemia—Methotrexate—lymphatic system cancer	0.000255	0.00131	CcSEcCtD
Vorinostat—Leukopenia—Methotrexate—lymphatic system cancer	0.000247	0.00127	CcSEcCtD
Vorinostat—Cough—Methotrexate—lymphatic system cancer	0.00024	0.00124	CcSEcCtD
Vorinostat—HDAC2—Disease—NPM1—lymphatic system cancer	0.000239	0.00163	CbGpPWpGaD
Vorinostat—Chest pain—Methotrexate—lymphatic system cancer	0.000235	0.00121	CcSEcCtD
Vorinostat—Infection—Methotrexate—lymphatic system cancer	0.000223	0.00115	CcSEcCtD
Vorinostat—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00022	0.00113	CcSEcCtD
Vorinostat—Anorexia—Methotrexate—lymphatic system cancer	0.000214	0.0011	CcSEcCtD
Vorinostat—Decreased appetite—Methotrexate—lymphatic system cancer	0.000196	0.001	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000194	0.000998	CcSEcCtD
Vorinostat—Fatigue—Methotrexate—lymphatic system cancer	0.000194	0.000997	CcSEcCtD
Vorinostat—Body temperature increased—Methotrexate—lymphatic system cancer	0.000178	0.000914	CcSEcCtD
Vorinostat—Asthenia—Methotrexate—lymphatic system cancer	0.000161	0.000829	CcSEcCtD
Vorinostat—Pruritus—Methotrexate—lymphatic system cancer	0.000159	0.000818	CcSEcCtD
Vorinostat—Diarrhoea—Methotrexate—lymphatic system cancer	0.000154	0.000791	CcSEcCtD
Vorinostat—Dizziness—Methotrexate—lymphatic system cancer	0.000149	0.000764	CcSEcCtD
Vorinostat—Vomiting—Methotrexate—lymphatic system cancer	0.000143	0.000735	CcSEcCtD
Vorinostat—Headache—Methotrexate—lymphatic system cancer	0.000141	0.000724	CcSEcCtD
Vorinostat—Nausea—Methotrexate—lymphatic system cancer	0.000134	0.000687	CcSEcCtD
